RecruitingNot ApplicableNCT03692598

Study of Transcatheter Tricuspid Annular Repair

Sponsor

Micro Interventional Devices

Enrollment

60 participants

Start Date

Dec 1, 2016

Study Type

INTERVENTIONAL

Conditions

Tricuspid Regurgitation

Summary

The purpose of the study is to evaluate the safety and performance of the MIA Minimally Invasive Annuloplasty Device in patients with chronic functional tricuspid regurgitation.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MIA, Minimally Invasive Annuloplasty Device - Percutaneous and MIA, Minimally Invasive Annuloplasty Device - Surgical for people with tricuspid regurgitation. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years to 85 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMIA, Minimally Invasive Annuloplasty Device - Surgical

Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from an open surgical approach

DEVICEMIA, Minimally Invasive Annuloplasty Device - Percutaneous

Eligible patients will receive implantation of MIA implants deployed using the MIA, Minimally Invasive Annuloplasty Device from a percutaneous approach

Locations(6)

Aarhus University Hospital

Aarhus, Denmark

Semmelweis University, Heart and Vascular Center

Budapest, Hungary

Centre of Cardiology, Pauls Stradins Clinical University Hospital

Riga, Latvia

Lithuanian University of Health Sciences

Kaunas, Lithuania

Vilnius University Hospital Santariskiu Klinikos

Vilnius, Lithuania

The Cardinal Stefan Wyszyński Institute of Cardiology

Warsaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03692598

Related Trials

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

NCT0584828411 locations

Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation

NCT070423601 location